Evan R DeVallance (Evan DeVallance)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Polycyclic Aromatic Hydrocarbons

Vascular Endothelial Growth Factor

Left Ventricular

Top Venues

Antioxidants (Basel, Switzerland)

Cardiovascular toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Evan R DeVallance, Christopher M Dustin, Daniel Simoes de Jesus, Imad Al Ghouleh, John C Sembrat, Eugenia Cifuentes-Pagano, Patrick J Pagano
Specificity Protein 1-Mediated Promotion of CXCL12 Advances Endothelial Cell Metabolism and Proliferation in Pulmonary Hypertension. Antioxidants (Basel, Switzerland) 12 (1) (2022)
Krista L Garner, Elizabeth C Bowdridge, Julie A Griffith, Evan R DeVallance, Madison G Seman, Kevin J Engels, Caroline P Groth, William T Goldsmith, Kim Wix, Thomas P Batchelor, Timothy R Nurkiewicz
Maternal Nanomaterial Inhalation Exposure: Critical Gestational Period in the Uterine Microcirculation is Angiotensin II Dependent. Cardiovascular toxicology 22 (2) (2022)
Evan R DeVallance, Christopher M Dustin, Daniel Simoes de Jesus, Imad Al Ghouleh, John C Sembrat, Eugenia Cifuentes-Pagano, Patrick J Pagano
Specificity Protein 1-Mediated Promotion of CXCL12 Advances Endothelial Cell Metabolism and Proliferation in Pulmonary Hypertension. Antioxidants (Basel, Switzerland) 12 (1) (2022)